Avian Hepatitis E Virus (avian HEV) and Its Uses Thereof

Description:
Novel avian hepatitis E virus, immunogenic compositions, diagnostic reagents, vaccines and methods of detection or protecting against avian hepatitis-splenomegaly syndrome and mammalian Hepatitis E.

US Patents:

                 7,005,130 - Issued February 26, 2006

                 7,582,303 - Issued September 1, 2009

                 7,842,298 - Issued November 30, 2010

  

 


 

  
Patent Information:
Title App Type Country Serial No. Patent No. File Date Issued Date Expire Date
Avian Hepatitis E Virus, Vaccines and Methods of Protecting Against Avian Hepatitis-Splenomegaly Syndrome and Mammalian Hepatitis E US Utility *United States 10/029,840 7,005,130 12/31/2001 2/28/2006 9/26/2022
Avian Hepatitis E Virus, Vaccines and Methods of Protecting Against Avian Hepatitis-Splenomegaly Syndrome and Mammalian Hepatitis E US Divisional *United States 11/184,574 7,582,303 7/19/2005 9/1/2009 2/18/2022
Avian Hepatitis E Virus, Vaccines and Methods of Protecting Against Avian Hepatitis-splenomegaly Syndrome and Mammalian Hepatitis E US Divisional *United States 12/507,576 7,842,298 7/22/2009 11/30/2010 1/5/2021
Category(s):
Animal/Veterinary
For Information, Contact:
Rob Whitehead
Senior Licensing Manager
Virginia Tech Intellectual Properties, Inc.
(540) 443-9219
rwhitehead@vtip.org
Inventors:
Xiang-Jin Meng
Gholamreza Haqshenas
Fang-Fang Huang
Keywords:
Animal Health
Pharmaceuticals & Biotechnology
© 2017. All Rights Reserved. Powered by Inteum